(Q57723879)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Cost analysis of the treatment of schizophrenia in the UK: a comparison of olanzapine and haloperidol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

S Almond

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

5 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

575-588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165324%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199813050-00010

23 December 2019

exact match

0 references

cites work

Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia

1 reference

12 December 2020

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

1 reference

12 December 2020

A controlled trial of home-based acute psychiatric services. II: Treatment patterns and costs.

1 reference

12 December 2020

Disabilities and circumstances of schizophrenic patients--a follow-up study. Comparison of the 1975-85 cohort with the 1970-75 cohort

1 reference

12 December 2020

Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia

1 reference

12 December 2020

Negative and positive symptoms in schizophrenia and depression: a followup

1 reference

12 December 2020

Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients.

1 reference

12 December 2020

Suicide and schizophrenia: data from a prospective community treatment study

1 reference

12 December 2020

Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective study

1 reference

12 December 2020

The TAPS project. 3: Predicting the community costs of closing psychiatric hospitals

1 reference

12 December 2020

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

12 December 2020

Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.

1 reference

12 December 2020

Costs of schizophrenia

1 reference

12 December 2020

The positive-negative distinction in schizophrenia. Review of natural history validators

1 reference

12 December 2020

Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.

1 reference

12 December 2020

The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics

1 reference

12 December 2020

Schizophrenia: shifting the balance of care

1 reference

12 December 2020